July 12, 2026 06:48 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Highway blocked, stones pelted, cops injured': BJP faces open revolt in Madhya Pradesh over Narottam Mishra ticket snub | Two Kolkata Police DCPs suspended over alleged remarks against Bengal CM Suvendu Adhikari | Bail to Bloodbath: Telangana man allegedly kills wife, kids and teen who accused him of sexual harassment | Prakash Raj gets bail in multiple voter registration case linked to 2019 polls | ED raids Shekhar Suman associate's premises in FEMA case; phone allegedly thrown from 13th floor | 'Candidate fled': Prashant Kishor jibes BJP over Bankipur nominee change | BJP replaces candidate days before high-stakes Bankipur bypoll | Foreign franchise league enters India! BBL opener to be played in Chennai, announce Modi-Albanese | 'They could have stopped me': Vijay blames police, former DMK government over Karur stampede | 'People will correct their 2025 mistake': Electoral debutant Prashant Kishor predicts BJP defeat in Bankipur

UN hails landmark pricing deal for faster rollout of ‘game-changing’ HIV treatment

| @indiablooms | Sep 22, 2017, at 04:58 pm
New York, Sept 22(Just Earth News): Senior United Nations officials on Thursday welcomed a breakthrough pricing agreement by global partners to accelerate the availability in low- and middle-income countries of the first affordable, generic, single-pill HIV treatment regimen.

“What we are talking about on Thursday with this life-changing announcement is about the quality of medicine, is about equity, is about the dignity, is about access to medicine as a human right,” Michel Sidibé, Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS), told a press conference at UN Headquarters.

The pricing agreement, he explained, will help ensure that the treatment will be made available to 92 countries, and people there will be able to benefit from “one of the best medicines we have” for first-line treatment.

At around $75 per person per year, the HIV treatment regimen containing dolutegravir (DTG) will be available to public-sector purchasers in these countries.

The agreement is expected to accelerate treatment rollout as part of global efforts to reach all 36.7 million people living with HIV with high-quality antiretroviral therapy. UNAIDS estimates that in 2016, 19.5 million – or just over half of all people living with HIV – had access to the life-saving medicines.

DTG, a best-in-class integrase inhibitor, is widely used in high-income countries and is recommended by the World Health Organization (WHO) as an alternative first-line HIV regimen. It is also a preferred treatment by the United States Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, among others.

WHO Director-General Tedros Adhanom also welcomed the agreement, stating that “this will save lives for the most vulnerable, bringing the world closer to the elimination of HIV […] WHO will support countries in the safe introduction and a swift transition to this game-changing new treatment.”

The agreement was announced by the Governments of South Africa and Kenya, together with UNAIDS and many other partners.

Earlier on Thursday, during an event entitled “Fast-Track: Quickening the pace of action to end AIDS” held on the sidelines of the General Assembly, Sidibé called on world leaders to maintain “global solidarity” to end AIDS.

UNAIDS leads global efforts to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths.

Photo: © Masaru Goto / World Bank

 

Source: www.justearthnews.com

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.